AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 231 min read$FPH

Five Point Holdings 3Q 2026: Revenue $14.6M, Net loss $2.6M, EPS $(0.04) — 10-Q Summary

Five Point Holdings reported 3Q 2026 revenue of $14.6M, up 8.4% YoY, and a net loss of $2.6M, compared to a $21.1M profit last year. EPS was $(0.04). Revenue growth was driven by Hearthstone management fees, while Great Park fees declined. The company began infrastructure work at Candlestick and received approval for 3,600 homesites at Valencia.

Original reporting
tradingview.com
Published Oct 23, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Five Point Holdings 3Q 2026: Revenue $14.6M, Net loss $2.6M, EPS $(0.04) — 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$FPHBearishLow
01

Why it matters

The earnings miss may trigger short‑term downside pressure, but the company's asset base and fee revenue could provide longer‑term upside.

02

Market read

The filing provides the first public numbers for the quarter, offering a modest trading signal for the stock.

03

What to watch

Management fees from Hearthstone assets and upcoming land approvals may support future revenue growth.

Relevance 5/10Novelty 5/10Timing: post‑market filing

Background

Five Point Holdings is a micro‑cap land‑development company that recently disclosed its Q3 2026 earnings via a 10‑Q filing.

Company-level read

Ticker impact

$FPHBearishMedium confidence
Context

Five Point Holdings reported Q3 2026 results with revenue $14.6M and a net loss of $2.6M, a fresh earnings disclosure.

Expected impact

likely pressure as the market prices in the unexpected loss versus prior-year profit

Evidence & confidence

The company posted a loss after a profit year‑ago, indicating weaker performance and may trigger sell‑offs.

Market effects

Sector

Minimal impact on broader home‑building or real‑estate sector due to the company's small size.

Regional

Limited to niche land‑development markets; unlikely to affect regional indices.

Global

Negligible

Counterpoint

What could challenge this read

If the loss is viewed as a one‑off adjustment and the underlying land inventory remains strong, the stock could be undervalued.

Key entities

  • company
    Five Point Holdings

    Land‑development firm reporting Q3 2026 earnings.

Read at source← All news

Related articles

OCT 22
$FPHMed

Five Point Q3 Earnings Call Highlights

Five Point (FPH) expects small Q4 net income and $20M for 2026, adjusting land sale expectations. Q3 saw 54 homes sold at Great Park, 92 at Valencia. Cash position: $358.7M, liquidity: $576.2M. CFO Tobler forecasts >$300M cash by 2026, with $125M development spending planned. Management revenue: $13.9M, Hearthstone AUM: $3.4B. Progress reported at Valencia and Candlestick.

finance.yahoo.com2 min
OCT 22
$FPHMed

Five Point Holdings, LLC Reports Third Quarter 2026 Results

Five Point Holdings, LLC (FPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Five Point Holdings, LLC Reports Third Quarter 2026 Results Third Quarter 2026 Highlights • Great Park Venture distributions and incentive compensation payments to the Company totaled $40.4 million. • Great Park builder sales of 54 homes during the quarter. • Valenci

SEC EDGAR 8-K2 min
SEP 16
$RMDMed

CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded

RBC Capital Markets upgraded five ASX-listed healthcare stocks to outperform, citing positive earnings growth and attractive valuations. CSL (ASX: CSL) was highlighted for market share gains, with a $213 price target. ResMed (ASX: RMD) was noted for capital management, with a $262 target. Ramsay Healthcare (ASX: RHC) was praised for cost control, with a $68 target. Fisher & Paykel (ASX: FPH) showed strong growth, with a $52 target. Nanosonics (ASX: NAN) had mixed results but a $3.75 target.

fool.com.au2 min
AUG 21
$FPHMedAI 8/10

Market quiet but earnings showing positive signs

Fisher & Paykel Healthcare upgraded its 2027 guidance, citing strong hospital product sales. Revenue and net profit forecasts increased, with first-half revenue expected at $1.24B and net profit at $280M. The stock closed at $43.52. On Wall Street, the Dow fell 1.32% as bond yields rose and Walmart missed earnings. In NZ, several companies reported earnings, including South Port NZ and Seeka.

nzherald.co.nz2 min
AUG 17
$FPHMed

FPH turns down KKR bid for First Gen stake over valuation

First Philippine Holdings (FPH) rejected KKR’s non-binding bid to buy an additional 8.43% stake in First Gen and then tender for First Gen’s public float at P36/share, saying it undervalues First Gen. FPH owns 67.84% of First Gen; KKR has 19.9% economic interest. The deal would have supported a delisting. First Gen also weighs a $5B offer from BREN for EDC.

bworldonline.com5 min